Arawan’s Medical Weight Loss Management Program is a cornerstone for individuals seeking a comprehensive, medically supervised approach to weight loss. Our program employs a partnership with compounding pharmacies with advanced certifications. These pharmacies play a crucial role in our program, as they are responsible for preparing personalized medications and supplements tailored to each patient's unique needs, ensuring effective and personalized care.
Here’s why this program is significant:
Personalized and Comprehensive Care
Tailored Plans: Each patient receives a customized weight loss plan based on their medical history, current health status, and personal goals.
Holistic Approach: The program addresses diet, exercise, behavioral, and psychological factors influencing weight gain and loss.
Medical Supervision
Expert Guidance: Our medical professionals oversee the medical weight loss management program, monitor patients’ progress, and adjust plans as necessary.
Safety: Medical supervision ensures that weight loss methods are safe and effective, especially for individuals with underlying health conditions.
Utilization of Advanced Medications
Metformin: Often used to treat type 2 diabetes, Metformin can also aid in weight loss of 2% to 3% in body weight in 52 weeks or one year by improving insulin sensitivity and reducing appetite.
Liraglutide (Brand name Victoza & Saxenda): A GLP-1 receptor agonist used for both type 2 diabetes and weight management, aiding in appetite control and weight reduction with an overall weight loss reduction of greater or equal to 9.2% in 16 weeks with daily injections when paired with a healthy and active lifestyle.
Dulaglutide (Brand name Trulicity): Another GLP-1 receptor agonist that is not indicated for weight loss but can help with glucose control while losing weight through appetite control allowed patients to lose 5% or higher reduction in weight loss with weekly injections in 52 weeks.
Semaglutide (Brand names Ozempic and Wegovy): It has been proven highly effective for weight loss. Ozempic was used for diabetes and helped patients lose weight. Novo Nordisk, the manufacturing company, added a new brand called Wegovy for weight loss. The two brands comprise the same GLP1 compound, helping regulate appetite and blood sugar levels. It has shown a 15% to 20% reduction in 68 weeks.
Tirzepatide (Brand name Moujaro and Zepbound): An injectable medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, shown to reduce weight significantly on a weekly injection. Weight loss survey was about 20% to 30% in over 72 weeks or 18 months.
Evidence-Based Methods
Research-Backed: By incorporating the latest research and clinical guidelines, Arawan ensures patients receive the most effective treatments.
Innovative Treatments: The program includes cutting-edge solutions by staying updated with new developments in weight loss science.
Comprehensive Support
Multidisciplinary Team: Patients benefit from a team of dietitians, fitness experts, and mental health professionals working together to support their journey.
Ongoing Support: Continuous monitoring and support help patients stay on track and address challenges as they arise.
Improved Health Outcomes
Chronic Disease Management: Effective weight loss can reduce the risk of chronic diseases such as type 2 diabetes, cardiovascular disease, and certain cancers.
Enhanced Quality of Life: Beyond physical health, patients often experience improved mental well-being and greater confidence.
Comments